Patent · US Active

Methods and compositions involving miRNA and miRNA inhibitor molecules

US9506061B2 · kind B2 · utility

152Cited by

163References

7Claims

0Family size

Assignee

ASURAGEN, INC. · US

Inventors

David Brown · Brighton, US
Lance Ford · Austin, US
Angie Cheng · Austin, US
Rich Jarvis · Austin, US
Mike Byrom · Austin, US
Dmitriy Ovcharenko · Austin, US
Eric Devroe · Pflugerville, US
Kevin Kelnar · Kyle, US

Key dates

Filing date	May 14, 2015
Grant date	Nov 29, 2016
Priority date	—
Expiry date	May 14, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/178
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention concerns methods and compositions for introducing miRNA activity or function into cells using synthetic nucleic acid molecules. Moreover, the present invention concerns methods and compositions for identifying miRNAs with specific cellular functions that are relevant to therapeutic, diagnostic, and prognostic applications wherein synthetic miRNAs and/or miRNA inhibitors are used in library screening assays.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.